Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Low Grade Astrocytoma — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Neuroepithelial, Perineurial, and Schwann Cell Neoplasm
Neuroepithelial Neoplasm
Glioma
Low Grade Glioma
Low Grade Astrocytoma

Subtype

Low Grade Astrocytoma

CI-CAN-00005775Explore in graph →

Non-malignant21 active trials16 evidence items

NCIt: C116342

Overview
Statistics
Survival
Genomics1
Variants & evidence16
Drugs5
Trials70
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (11)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 1–11 of 11 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.
· Nat Genet · 2013 · PMID 23817572 · validated civic_curation pubmed
Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas.
· Cancer Res · 2008 · PMID 18974108 · validated civic_curation pubmed
A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration.
· Acta Neuropathol · 2019 · PMID 31595312 · validated civic_curation pubmed
Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.
· Acta Neuropathol · 2020 · PMID 31563982 · validated civic_curation pubmed
Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1.
· Proc Natl Acad Sci U S A · 2013 · PMID 23633565 · validated civic_curation pubmed
Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
· Acta Neuropathol · 2016 · PMID 26810070 · validated civic_curation pubmed
Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent.
· J Transl Med · 2014 · PMID 25524464 · validated

Showing 1–11 of 11 publications

civic_curation

Activity of Pemigatinib in Pilocytic Astrocytoma and FGFR1N546K Mutation.

· JCO Precis Oncol · 2022 · PMID 35507888 · validated civic_curation pubmed

CDKN2A/B Loss Is Associated with Anaplastic Transformation in a Case of NTRK2 Fusion-positive Pilocytic Astrocytoma.

· Neuropathol Appl Neurobiol · 2019 · PMID 29804288 · validated civic_curation pubmed

MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas.

· Acta Neuropathol · 2010 · PMID 21046410 · validated civic_curation pubmed

Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing.

· Oncotarget · 2017 · PMID 28002790 · validated civic_curation pubmed